<DOC>
	<DOC>NCT00804414</DOC>
	<brief_summary>Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.</brief_summary>
	<brief_title>Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description>The objective of this study is to evaluate efficacy and safety of soluble beta-1,3/1,6-glucan (SBG) on chronic diabetic foot ulcers.</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patients with chronic diabetic foot ulcer Insufficient nutritional status, renal function or diabetes control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Diabetic ulcer</keyword>
	<keyword>Chronic ulcer</keyword>
	<keyword>SBG</keyword>
</DOC>